Vident Investment Advisory, LLC Iovance Biotherapeutics, Inc. Transaction History

Vident Investment Advisory, LLC

$0
Q3 2023

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$5.53 - $8.22 $18,182 - $27,027	-3,288 Reduced 2.85%	112,238 $685,000
Q4 2022 Feb 14, 2023	BUY	$5.62 - $10.0 $218,601 - $388,970	38,897 Added 50.76%	115,526 $738,000
Q3 2022 Nov 14, 2022	SELL	$9.53 - $13.11 $76,335 - $105,011	-8,010 Reduced 9.46%	76,629 $731,000
Q2 2022 Aug 15, 2022	BUY	$6.38 - $18.33 $130,368 - $374,555	20,434 Added 31.83%	84,639 $934,000
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $130,485 - $201,314	10,540 Added 19.64%	64,205 $1.07 Million
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $154,246 - $257,511	-9,320 Reduced 14.8%	53,665 $1.02 Million
Q3 2021 Nov 12, 2021	SELL	$20.35 - $26.63 $91,575 - $119,835	-4,500 Reduced 6.67%	62,985 $1.55 Million
Q2 2021 Aug 13, 2021	BUY	$16.33 - $33.07 $563,009 - $1.14 Million	34,477 Added 104.45%	67,485 $1.76 Million
Q4 2020 Feb 08, 2021	SELL	$28.04 - $50.26 $251,827 - $451,385	-8,981 Reduced 21.39%	33,008 $1.53 Million
Q3 2020 Nov 12, 2020	SELL	$27.75 - $36.3 $168,914 - $220,958	-6,087 Reduced 12.66%	41,989 $1.38 Million
Q2 2020 Jul 17, 2020	SELL	$27.21 - $41.0 $315,935 - $476,051	-11,611 Reduced 19.45%	48,076 $1.32 Million
Q1 2020 May 12, 2020	SELL	$19.54 - $38.85 $33,921 - $67,443	-1,736 Reduced 2.83%	59,687 $1.79 Million
Q4 2019 Feb 11, 2020	SELL	$17.95 - $29.41 $206,317 - $338,038	-11,494 Reduced 15.76%	61,423 $1.7 Million
Q3 2019 Nov 13, 2019	SELL	$17.99 - $26.0 $37,473 - $54,158	-2,083 Reduced 2.78%	72,917 $1.33 Million
Q2 2019 Aug 12, 2019	SELL	$9.78 - $24.52 $797,021 - $2 Million	-81,495 Reduced 52.08%	75,000 $1.84 Million
Q1 2019 May 08, 2019	SELL	$8.41 - $11.26 $43,412 - $58,124	-5,162 Reduced 3.19%	156,495 $1.49 Million
Q4 2018 Feb 14, 2019	SELL	$7.51 - $11.93 $133,843 - $212,616	-17,822 Reduced 9.93%	161,657 $1.43 Million
Q3 2018 Nov 14, 2018	SELL	$11.25 - $17.7 $145,575 - $229,038	-12,940 Reduced 6.72%	179,479 $2.02 Million
Q2 2018 Aug 14, 2018	SELL	$12.45 - $16.95 $222,991 - $303,591	-17,911 Reduced 8.52%	192,419 $2.46 Million
Q1 2018 May 14, 2018	BUY	$8.1 - $19.5 $462,801 - $1.11 Million	57,136 Added 37.3%	210,330 $3.1 Million
Q4 2017 Feb 15, 2018	SELL	$6.65 - $9.25 $215,686 - $300,014	-32,434 Reduced 17.47%	153,194 $1.23 Million
Q3 2017 Nov 14, 2017	BUY	$4.45 - $8.55 $826,044 - $1.59 Million	185,628	185,628 $1.44 Million

Others Institutions Holding IOVA

# of Institutions

314

Shares Held

241M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.35B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Account